Anti-bacteria Medicine - PowerPoint PPT Presentation

1 / 42
About This Presentation
Title:

Anti-bacteria Medicine

Description:

Anti-bacteria Medicine Anti-bacteria medicine Antibiotics: The substance derived from fungi and bacteria which can selectively kill or inhibit bacteria growth Anti ... – PowerPoint PPT presentation

Number of Views:87
Avg rating:3.0/5.0
Slides: 43
Provided by: gyz
Category:

less

Transcript and Presenter's Notes

Title: Anti-bacteria Medicine


1
Anti-bacteria Medicine

2
Anti-bacteria medicine
  • Antibiotics The substance derived from fungi and
    bacteria which can selectively kill or inhibit
    bacteria growth
  • Anti-bacteria medicine Chemically synthesized
    medicine which can selectively kill or inhibit
    bacteria growth

3
(No Transcript)
4
Antibacteria medicine
  • Sulfonamide
  • Quilonones
  • others

5
(No Transcript)
6
Antibiotics and drugs targeting nucleic acid
biosynthesis and functions
7
Antibiotics and drugs targeting nucleic acid
biosynthesis and functions
  • 1. Sulphonamides Trimethoprim (TMP)
  • PABA false structure
  • Inhibition of Dihydrofolate reductase
  • Dihydrofolate ?? tetrahydrofolate

8
(No Transcript)
9
2. Quinolones Bacterial
topoisomerase
II- Gyrase
Antibiotics and drugs targeting nucleic acid
biosynthesis and functions
  • Nalidixic acid
  • Ofloxacin
  • Ciprofloxacin

10
(No Transcript)
11
Antibiotics and drugs targeting nucleic acid
biosynthesis and functions
  • 3. Rifampicin (from rifamycin)
  • ? subunit of DNA-primed RNA polymease

12
Antibiotics and drugs targeting nucleic acid
biosynthesis and functions
  • ! Rifampicin must be given by a cocktail of
    drugs.

13
(No Transcript)
14
(No Transcript)
15
(No Transcript)
16
(No Transcript)
17
Problem of antibiotics which inhibit protein
synthesis
18
(No Transcript)
19
Antibiotics From isolation of strain to
clinical application
  • Selection of a potential product
  • 1?efficacy
  • 2?metabolic characterization
  • 3?toxicity and adverse effect
  • 4?Potentiality of industrial production

20
Antibiotics from strain isolation to clinical
application
  • Semi-synthesis the most popular approach of
    production
  • Marketing potentiality
  • Life-span of marketing and its impact

21
(No Transcript)
22
Patients withpneumonia and bacteria in blood
Penicillin
överlevare
Penicillin increased the chance of survival from
10 to 90
Obehandlade
Dagar
23
It is not difficult to make microbes resistant
to penicillin The time may come when
penicillin can be bought by anyone in the shops
Alexander Fleming's Nobel Lecture, 1945
24
(No Transcript)
25
The Global Challenge Antibiotics have
saved millions of lives Antibiotics are rapidly
losing their effect
26
What is Antibiotic Resistance?
27
Bacterial Resistance to Antibiotics
  • ? Enzymes secreted (exo-enzyme)
  • ? Enzymes not secreted (endo-enzymes)
  • ? Deletion of target molecules
  • ? Change in cell permeability
  • ? Change in target molecule affinity
  • ? Speed-up of synthesis and metabolism
  • ? Others

28
Mechanism of resistance
  • Selection pressure ( not only in health
    institutions)
  • Genetic recombination ( especially conjugation
    mediated by plasmid)

29
Improper prescription of antibiotics
  • Antibiotic prescription for non-bacterial
    infection
  • Prophylaxis application of antibiotics
  • Local application of antibiotics
  • Over use of wide-spectrum antibiotics
  • Long-term use of antibiotics
  • Antibiotic abuse in agriculture production

30
Modern Medicine Is Not Possible Without Effective
Antibiotics
Hip replacement
Organ transplants
Cancer chemotherapy
Care of preterm babies
31
The survival of the fittest
32
(No Transcript)
33
Horisontal spread of resistance genes
Spread of resistance between species
34
Barrier to the development of new antibiotics
  • Short marketing life of the product because of
    resistance
  • Difficult RD
  • 1?qualified strain
  • 2?resources to support RD
  • 3?long term research and translation
  • Adverse reactions
  • Expense for health care

35
The outcome of resistance development (From the
view point of bacteria cells)
  • ? Uneconomic state of cell metabolism
  • ? Slow-down of proliferation
  • ? deletion of some pathogenic abilities
  • ? Avoiding harms from drugs

36
(No Transcript)
37
Antibiotic sensitivity test
  • MIC MBC
  • ? Broth dilution
  • ? Agar dilution
  • ? Disk diffusion
  • ? Standard requirements

38
(No Transcript)
39
Antibiotic sensitivity test
  • Standard requirements
  • a.   Depth 4mm
  • b.  Inoculates 105 cell/ml
  • c.   Incubation 37?, 18 hours

40
Antibiotic Sensitivity Test
  • ? How to explain the results?
  • ? How to avoid misleading of clinicians?
  • ? How to standardize the test?

41
Reading and evaluation of sensitivity test
  • 1?Physical and chemical profile of the
    medicine
  • 2?Metabolic process
  • 3?Identification of sensitivity resistance
  • 4?Q.C.
  • 5?Who is responsible for those work?

42
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com